Navigation Links
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
Date:8/4/2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- The International Society for Medical Publication Professionals ... continuing to accept abstracts for its 6th Annual ... April 19-21, 2010. This marks the first time ... the organization to submit an abstract to this ... AM EST, January 15, 2010. For submission details, ...
(Date:12/15/2009)... N.Y., Dec. 15 On January 20th, ... Society for Medical Publication Professionals (ISMPP) will be ... London, UK. More than 100 attendees are expected ... for publication professionals, editors, publishers, medical writers and ... medical publications and the impact of guidelines and ...
(Date:12/15/2009)... -- , - 45 ... Ability of,Cardiopoietic Cells to Restore Cardiac Function ,, ... Belgian biotechnology company specialising,in cell-based therapies for the ... completed, two months ahead of schedule,enrolment in the ... of C-Cure, a,unique stem cell therapy for heart ...
(Date:12/14/2009)... and THOUSAND OAKS, Calif., Dec. 14 ... Amgen Inc.(Nasdaq: AMGN ) today announced that ... worldwide rights to Array,s small-molecule glucokinase activator program, ... 1 clinical trial in patients with Type 2 ... the agreement, Array will receive an upfront payment ...
Breaking Biology Technology:The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 2Cardio3 BioSciences Completes Patient Enrolment in First Stage of Pivotal Trial of C-Cure(R) in Heart Failure 3Array BioPharma and Amgen Partner in Type 2 Diabetes 2Array BioPharma and Amgen Partner in Type 2 Diabetes 3Array BioPharma and Amgen Partner in Type 2 Diabetes 4Array BioPharma and Amgen Partner in Type 2 Diabetes 5Array BioPharma and Amgen Partner in Type 2 Diabetes 6Array BioPharma and Amgen Partner in Type 2 Diabetes 7
... the leading,management consulting firm specializing in the pharmaceutical ... President,in the firm,s Sales Practice, will present a ... The event will be held from,April 2 to ... Spain., Mr. Schmidt,s 90-minute workshop, titled "Positioning ...
... BEIJING and CLAREMONT, Calif., March 26 /Xinhua-PRNewswire-FirstCall/,-- Kiwa ... that revenues for the year ended December 31, ... for 2006., Net sales from continuing operations ... December 31, 2007 and 2006, respectively,representing an increase ...
... Inc.,(Amex: PIP ) a biodefense company ... countermeasures against chemical and,biological terrorism, announced today ... providing an additional value of $5.8 million ... spectrum chemical nerve,agent prophylaxis., In September ...
Other Biology Technology:Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference 2Campbell Alliance Sales Practice to Conduct Workshop at EyeForPharma SFE Europe Conference 3Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million 2Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million 3Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million 4Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million 5Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million 6Kiwa Bio-Tech Year-End Revenues Increase 264% - Exceed $9.1 Million 7Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program 2Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program 3Department of Defense Awards $5.8 Million Contract Modification Providing Additional Funding for PharmAthene's Protexia(R) Program 4
(Date:12/15/2009)... Ghent, 15 December 2009 - Scientists at VIB and ... ally for the treatment of septic shock, the major ... the release of nitric oxide (NO) gas in mice ... discovered that the animal,s organs showed much less damage, ... to all expectations, since it is generally assumed that ...
(Date:12/15/2009)... the near future, consumers can look forward to ... as laptops, PDAs and mobile phones. This is ... harvesting technologies which are critical elements for power ... and systems. , Analog IC design is the ... harvesting. To pre-position the nation in advanced analog ...
(Date:12/14/2009)... -- Researchers at Rice University and Baylor College of ... be tracked in real time with MRI as it ... fluorescent dye and kills them with heat. The all-in-one ... growing field called "theranostics" that develops technologies physicians can ... procedure. , The research is available online in the ...
Breaking Biology News(10 mins):Septic shock: Nitric oxide beneficial after all 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Tracking new cancer-killing particles with MRI 2Honoring Those Who Help Make Blood Safe and Available 56839 1Honoring Those Who Help Make Blood Safe and Available 56839 2Honoring Those Who Help Make Blood Safe and Available 56839 3Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 1Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 2Most Pharmaceutical Companies Receive Poor Grades on HIV AIDS Drug Development Innovation According to AIDS Treatment Activist Coalition Report Card 56837 3Allied Worlds David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium 56835 1Allied Worlds David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium 56835 2Allied Worlds David Bell to Present as Keynote Speaker at 2009 Entrepreneurial Insurance Symposium 56835 3
... WI, MAY 18, 2009 Pharmaceuticals and personal care ... sludge) may reach surface waters or groundwater when ... land. During the high flow conditions created by ... residence time of solutes in soil macropores may ...
... Barron and his group, working with labs in Italy, Germany ... means by which the deadly virus spreads by taking away ... computer simulations, researchers tested more than 100 carbon fullerene, or ... see if they could be used to inhibit a strain ...
... a patient,s healthy tissue as well as eradicating the ... especially invasive and often causing nasty side effects. , ... more precise and accurate treatment for cancerous tumours by ... Real-time image-guided radiotherapy, combining radiation treatment with non-invasive MR ...
Other Biology News:Simulating pharmaceutical and personal care product transport 2International team tracks clues to HIV 2International team tracks clues to HIV 3